What is the equity of Centogene this year?
Centogene has equity of -25.28 M EUR this year.
Centogene Equity 2024
Centogene Equity
-25.28 M EUR
Ticker
CNTGF
ISIN
NL0014040206
WKN
A2PUCU
In 2024, Centogene's equity was -25.28 M EUR, a -441.65% increase from the 7.4 M EUR equity in the previous year.
Centogene Aktienanalyse
What does Centogene do?
Centogene NV is a biotechnology company specializing in the research and diagnosis of rare genetic diseases. It was founded in 2006 by Arndt Rolfs and Christoph Lengauer in Rostock. The business model of Centogene NV is based on the application of genomic research and advanced technologies to develop novel diagnostic and therapeutic approaches. The company operates its own laboratories where DNA samples are analyzed and evaluated. The goal is to identify the genetic causes of rare diseases and provide patients with personalized treatment options. The company operates in several areas. One focus is on the diagnosis of rare diseases that have unclear genetic causes. The company offers a wide range of genetic tests that aim to enable fast and precise diagnosis. These include exome sequencing, RNA analysis, and gene panel tests. Another business field of Centogene NV is the development of new therapy approaches for rare diseases. The company collaborates with pharmaceutical companies and clinical researchers to develop innovative drugs and conduct clinical trials. The aim is to offer improved treatment options and enhance the quality of life for patients with rare diseases. Centogene NV is headquartered in Rostock, Germany, but also has offices in Lisbon, Portugal, Dubai, United Arab Emirates, and Boston, USA. The company operates globally and collaborates with medical centers and research laboratories worldwide. A special feature of Centogene NV is the CentoMD® database system. This is an extensive genetic database that contains clinical and genetic information from patients with rare diseases. This database is a valuable resource for diagnosis, research, and the development of new therapy approaches. The company works closely with patient groups and international organizations to raise awareness of rare diseases and create better treatment options. Centogene NV is also involved in the education and training of medical professionals to ensure better care for patients. Overall, Centogene NV is a leading company in the research and diagnosis of rare genetic diseases. The business model is based on the application of cutting-edge genomic research and technologies to provide patients with personalized treatment options. The company operates globally and has its own laboratories and extensive genetic database. Centogene NV is actively involved in research and education to improve the care of patients with rare diseases. Centogene ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Centogene's Equity
Centogene's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Centogene's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Centogene's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Centogene's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Centogene’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Centogene stock
What was the equity of Centogene compared to the previous year?
The equity of Centogene has increased/decreased by -441.65% decreased compared to the previous year.
What impact does a high equity have on investors of Centogene?
A high equity is advantageous for investors of Centogene as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Centogene?
A low equity can be a risk for investors of Centogene, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Centogene affect the company?
An increase in equity of Centogene can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Centogene affect the company?
A reduction in equity of Centogene can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Centogene?
Some factors that can affect the equity of Centogene include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Centogene so important for investors?
The equity of Centogene is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Centogene take to change the equity?
To change equity, Centogene can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Centogene pay?
Over the past 12 months, Centogene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Centogene is expected to pay a dividend of 0 EUR.
What is the dividend yield of Centogene?
The current dividend yield of Centogene is .
When does Centogene pay dividends?
Centogene pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Centogene?
Centogene paid dividends every year for the past 0 years.
What is the dividend of Centogene?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Centogene located?
Centogene is assigned to the 'Health' sector.
Wann musste ich die Aktien von Centogene kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Centogene from 10/1/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.
When did Centogene pay the last dividend?
The last dividend was paid out on 10/1/2024.
What was the dividend of Centogene in the year 2023?
In the year 2023, Centogene distributed 0 EUR as dividends.
In which currency does Centogene pay out the dividend?
The dividends of Centogene are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Centogene stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Centogene
Our stock analysis for Centogene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Centogene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.